Publications by authors named "Adam Azlan"

Claim this Profile
T
The miRNA Landscape of Leukemia - Cellular Actions to Therapy through Molecular Mechanisms.
Kang Zi Khor, Adam Azlan, Julia Joseph, Jeyrubini Ramesh, Maheswaran Solayappan

Cell Biochem Biophys· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current progress in the elucidation of Acute Myeloid Leukemia (AML) immune landscapes.
Adam Azlan, Norashikin Zakaria, Mohd Rifqi Rafsanjani, Maheswaran Solayappan, Mot Yee Yik

Crit Rev Oncol Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SKP2 regulates TERT independently of RUNX1/ETO in AML subtypes lacking the t(8,21) translocation via CDKN1B and RB phosphorylation states.
Adam Azlan, Yaashini Rajasegaran, Aliaa Arina Rosli, Mohamed Saleem, Narazah Mohd Yusoff

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifaceted roles of CRISPR technology in blood cancer research.
Maheswaran Solayappan, Adam Azlan, Kang Zi Khor, Mot Yee Yik, Aswani Jaishanker

Curr Opin Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory role of miRNAs in nasopharyngeal cancer involving PTEN/PI3K/AKT, TGFβ/SMAD, RAS/MAPK, Wnt/β-catenin and pRB-E2F signaling pathways: A review.
Rabiatul Basria S M N Mydin, Adam Azlan, Simon I Okekpa, Nigel J Gooderham

Cell Biochem Funct· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applications.
Aliaa Arina Rosli, Adam Azlan, Yaashini Rajasegaran, Yee Yik Mot, Olaf Heidenreich

Clin Exp Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RUNX1/ETO regulates reactive oxygen species (ROS) levels in t(8,21) acute myeloid leukaemia via FLT3 and RAC1.
Adam Azlan, Kang Zi Khor, Yaashini Rajasegaran, Aliaa Arina Rosli, Mohamed Saifulaman Mohamed Said

Med Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A RUNX1/ETO-SKP2-CDKN1B axis regulates expression of telomerase in t (8;21) acute myeloid leukemia.
Emmanuel J Moses, Adam Azlan, Kang Zi Khor, Yee Yik Mot, Saleem Mohamed

Cell Mol Life Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elucidating miRNA Function in Cancer Biology via the Molecular Genetics' Toolbox.
Adam Azlan, Yaashini Rajasegaran, Khor Kang Zi, Aliaa Arina Rosli, Mot Yee Yik

Biomedicines· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and Clinical Implications.
Maheswaran Solayappan, Adam Azlan, Kang Zi Khor, Mot Yee Yik, Matiullah Khan

Front Genet· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Footprints of microRNAs in Cancer Biology.
Yaashini Rajasegaran, Adam Azlan, Aliaa Arina Rosli, Mot Yee Yik, Khor Kang Zi

Biomedicines· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of Human Telomerase Reverse Transcriptase () Regulation and Clinical Impacts in Leukemia.
Mot Yee Yik, Adam Azlan, Yaashini Rajasegaran, Aliaa Rosli, Narazah Mohd Yusoff

Genes (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis